These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 12003391)

  • 1. Rofecoxib and cytomegalovirus in acute flare-up of ulcerative colitis: coprecipitants or coincidence?
    Goh J; Wight D; Parkes M; Middleton SJ; Hunter JO
    Am J Gastroenterol; 2002 Apr; 97(4):1061-2. PubMed ID: 12003391
    [No Abstract]   [Full Text] [Related]  

  • 2. Safety of selective cyclooxygenase-2 inhibitors in inflammatory bowel disease.
    Mahadevan U; Loftus EV; Tremaine WJ; Sandborn WJ
    Am J Gastroenterol; 2002 Apr; 97(4):910-4. PubMed ID: 12008668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Acute ulcerative colitis in a patient treated with rofecoxib who took aspirin as self-medication].
    Charachon A; Petit T; Lamarque D; Soulé JC
    Gastroenterol Clin Biol; 2003 May; 27(5):511-3. PubMed ID: 12843913
    [No Abstract]   [Full Text] [Related]  

  • 4. Rofecoxib and early relapse of inflammatory bowel disease: an open-label trial.
    Biancone L; Tosti C; Geremia A; Fina D; Petruzziello C; Emerenziani S; Pallone F
    Aliment Pharmacol Ther; 2004 Apr; 19(7):755-64. PubMed ID: 15043516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rofecoxib and inflammatory bowel disease: clinical and pathologic observations.
    Wilcox GM; Mattia AR
    J Clin Gastroenterol; 2005 Feb; 39(2):142-3. PubMed ID: 15681911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ischemic colitis associated with rofecoxib.
    Radaelli F; Feltri M; Meucci G; Spinzi G; Terruzzi V; Minoli G
    Dig Liver Dis; 2005 May; 37(5):372-6. PubMed ID: 15843089
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute pancreatitis associated with rofecoxib.
    Amaravadi RK; Jacobson BC; Solomon DH; Fischer MA
    Am J Gastroenterol; 2002 Apr; 97(4):1077-8. PubMed ID: 12003405
    [No Abstract]   [Full Text] [Related]  

  • 8. [Acute ulcerative colitis and cytomegalovirus infection in a nonimmunosuppressed patient: delayed appearance of specific antibodies].
    Gallet E; Arsène D; Freymuth F; Caillez D; Valla A; Verwaerde JC
    Gastroenterol Clin Biol; 1985; 9(6-7):541-2. PubMed ID: 2991065
    [No Abstract]   [Full Text] [Related]  

  • 9. Exacerbation of Crohn's colitis with severe colonic hemorrhage in a patient on rofecoxib.
    Gornet JM; Hassani Z; Modiglian R; Lémann M
    Am J Gastroenterol; 2002 Dec; 97(12):3209-10. PubMed ID: 12492220
    [No Abstract]   [Full Text] [Related]  

  • 10. Severe cholestasis and acute renal failure related to rofecoxib.
    Linares P; Vivas S; Jorquera F; Olcoz JL; de Leon B; Oritz de Urbina J
    Am J Gastroenterol; 2004 Aug; 99(8):1622-3. PubMed ID: 15307886
    [No Abstract]   [Full Text] [Related]  

  • 11. Relationship between selective cyclooxygenase-2 inhibitors and acute myocardial infarction in older adults.
    Solomon DH; Schneeweiss S; Glynn RJ; Kiyota Y; Levin R; Mogun H; Avorn J
    Circulation; 2004 May; 109(17):2068-73. PubMed ID: 15096449
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leukocytoclastic vasculitis related to rofecoxib.
    Palop-Larrea V; Melchor-Penella MA; Ortega-Monzó C; Martínez-Mir I
    Ann Pharmacother; 2003 Nov; 37(11):1731-2. PubMed ID: 14565803
    [No Abstract]   [Full Text] [Related]  

  • 13. Intracranial hypertension induced by rofecoxib.
    Jacob S; Rajabally YA
    Headache; 2005 Jan; 45(1):75-6. PubMed ID: 15663617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute ulcerative colitis associated with cytomegalic inclusion virus.
    Tamura H
    Arch Pathol; 1973 Sep; 96(3):164-7. PubMed ID: 4352998
    [No Abstract]   [Full Text] [Related]  

  • 15. Intractable ulcerative colitis caused by cytomegalovirus infection: a prospective study on prevalence, diagnosis, and treatment.
    Wada Y; Matsui T; Matake H; Sakurai T; Yamamoto J; Kikuchi Y; Yorioka M; Tsuda S; Yao T; Yao S; Haraoka S; Iwashita A
    Dis Colon Rectum; 2003 Oct; 46(10 Suppl):S59-65. PubMed ID: 14530660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exacerbation of ulcerative colitis by cytomegalovirus infection in an immunocompetent Indian patient.
    Malhi NS; Bhasin DK; Gupta NM; Vaiphei K; Singh K
    Trop Gastroenterol; 2002; 23(2):88-90. PubMed ID: 12632977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rofecoxib (Vioxx) withdrawal: do product monographs adequately inform physicians?
    Can Fam Physician; 2005 Feb; 51(2):212-3. PubMed ID: 15751564
    [No Abstract]   [Full Text] [Related]  

  • 18. Lessons learned after the withdrawal of rofecoxib.
    Giaquinta D
    Manag Care Interface; 2004 Nov; 17(11):25-6, 46. PubMed ID: 15573801
    [No Abstract]   [Full Text] [Related]  

  • 19. [Role of allopurinol and rofecoxib in agranulocytosis and acute tubular necrosis].
    Real Panisello M; Vila Clérigues N; García Reina L; Luaces Vidal F; González Ponce CM; Díaz Carrasco MS
    Farm Hosp; 2003; 27(5):317-22. PubMed ID: 14576922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lessons on prescribing and drug safety from the withdrawal of rofecoxib.
    Nelson M; Cicuttini F
    Aust Fam Physician; 2004 Dec; 33(12):965-6. PubMed ID: 15630913
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.